83 related articles for article (PubMed ID: 19878356)
21. Development of a monoclonal antibody to the aP2 protein to identify adipocyte precursors in tumours of adipose differentiation.
Joyner CJ; Triffitt J; Puddle B; Athanasou NA
Pathol Res Pract; 1999; 195(7):461-6. PubMed ID: 10448662
[TBL] [Abstract][Full Text] [Related]
22. A contemporary review of myxoid adipocytic tumors.
Creytens D
Semin Diagn Pathol; 2019 Mar; 36(2):129-141. PubMed ID: 30853315
[TBL] [Abstract][Full Text] [Related]
23. Multiexponential T2 relaxometry of benign and malignant adipocytic tumours.
Nikiforaki K; Ioannidis GS; Lagoudaki E; Manikis GH; de Bree E; Karantanas A; Maris TG; Marias K
Eur Radiol Exp; 2020 Aug; 4(1):45. PubMed ID: 32743728
[TBL] [Abstract][Full Text] [Related]
24. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.
Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M
Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779
[TBL] [Abstract][Full Text] [Related]
25. Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours.
Salto-Tellez M; Nga ME; Han HC; Wong AS; Lee CK; Anuar D; Ng SS; Ho M; Wee A; Chan YH; Soong R
Br J Cancer; 2007 Mar; 96(5):776-82. PubMed ID: 17299397
[TBL] [Abstract][Full Text] [Related]
26. Pim-1 kinase expression during murine mammary development.
Gapter LA; Magnuson NS; Ng KY; Hosick HL
Biochem Biophys Res Commun; 2006 Jul; 345(3):989-97. PubMed ID: 16712793
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
[TBL] [Abstract][Full Text] [Related]
28. The role of microarray technologies in the study of soft tissue tumours.
West RB; van de Rijn M
Histopathology; 2006 Jan; 48(1):22-31. PubMed ID: 16359534
[TBL] [Abstract][Full Text] [Related]
29. The role of genetic testing in soft tissue sarcoma.
Antonescu CR
Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of human sarcomas: insights into sarcoma biology.
Baird K; Davis S; Antonescu CR; Harper UL; Walker RL; Chen Y; Glatfelter AA; Duray PH; Meltzer PS
Cancer Res; 2005 Oct; 65(20):9226-35. PubMed ID: 16230383
[TBL] [Abstract][Full Text] [Related]
32. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors.
Xia SJ; Barr FG
Eur J Cancer; 2005 Nov; 41(16):2513-27. PubMed ID: 16213703
[TBL] [Abstract][Full Text] [Related]
33. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
34. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.
Folpe AL; Goldblum JR; Rubin BP; Shehata BM; Liu W; Dei Tos AP; Weiss SW
Am J Surg Pathol; 2005 Aug; 29(8):1025-33. PubMed ID: 16006796
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.
Kumar A; Mandiyan V; Suzuki Y; Zhang C; Rice J; Tsai J; Artis DR; Ibrahim P; Bremer R
J Mol Biol; 2005 Apr; 348(1):183-93. PubMed ID: 15808862
[TBL] [Abstract][Full Text] [Related]
36. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint.
Bachmann M; Hennemann H; Xing PX; Hoffmann I; Möröy T
J Biol Chem; 2004 Nov; 279(46):48319-28. PubMed ID: 15319445
[TBL] [Abstract][Full Text] [Related]
37. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
Aho TL; Sandholm J; Peltola KJ; Mankonen HP; Lilly M; Koskinen PJ
FEBS Lett; 2004 Jul; 571(1-3):43-9. PubMed ID: 15280015
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability in colorectal cancer: considerations for molecular diagnosis and high-throughput screening of archival tissues.
Salto-Tellez M; Lee SC; Chiu LL; Lee CK; Yong MC; Koay ES
Clin Chem; 2004 Jun; 50(6):1082-6. PubMed ID: 15161730
[No Abstract] [Full Text] [Related]
39. Soft tissue sarcomas.
Cormier JN; Pollock RE
CA Cancer J Clin; 2004; 54(2):94-109. PubMed ID: 15061599
[TBL] [Abstract][Full Text] [Related]
40. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro.
Zippo A; De Robertis A; Bardelli M; Galvagni F; Oliviero S
Blood; 2004 Jun; 103(12):4536-44. PubMed ID: 14982870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
